Background: The role of human epidermal growth factor receptor 2 (HER2) in metaplastic breast cancer (MBC) patients remains unclear. The present study aimed to evaluate the effect of HER2 status on MB
Refined subtype labels and intrinsic probes. The refined breast cancer subtype labels defined for each sample in the METABRIC dataset are listed in Table S1. Table S2 shows the annotated probes select